Kevin Balthaser

Insider Reports History

Location
Wayne, PA
Signature
/s/ Matthew Rothman, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin Balthaser:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aclaris Therapeutics, Inc. Chief Financial Officer Common Stock 170,179 $597,328 $3.51 01 Feb 2026 Direct
Aclaris Therapeutics, Inc. Chief Financial Officer Restricted Stock Units 66,075 $4,726 $1.99 03 Feb 2026 Direct
Aclaris Therapeutics, Inc. Chief Financial Officer Employee Stock Option (Right to Buy) 346,800 02 Feb 2026 Direct

Insider Reports Filed by Kevin Balthaser

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ACRS Aclaris Therapeutics, Inc. 03 Feb 2026 3 -$22,378 4 Chief Financial Officer 05 Feb 2026, 16:41
ACRS Aclaris Therapeutics, Inc. 02 Feb 2026 2 $0 4 Chief Financial Officer 06 Feb 2026, 18:00
ACRS Aclaris Therapeutics, Inc. 01 Feb 2026 3 -$17,494 4 Chief Financial Officer 03 Feb 2026, 17:36
ACRS Aclaris Therapeutics, Inc. 31 Dec 2025 9 -$79,622 4 Chief Financial Officer 05 Jan 2026, 16:27
ACRS Aclaris Therapeutics, Inc. 01 Mar 2025 5 -$1,447 4 Chief Financial Officer 04 Mar 2025, 16:15
ACRS Aclaris Therapeutics, Inc. 01 Feb 2025 5 -$14,424 4 Chief Financial Officer 04 Feb 2025, 16:15
ACRS Aclaris Therapeutics, Inc. 31 Dec 2024 10 -$94,788 4 Chief Financial Officer 03 Jan 2025, 18:25
ACRS Aclaris Therapeutics, Inc. 01 Sep 2024 3 -$337 4 Chief Financial Officer 04 Sep 2024, 19:52
ACRS Aclaris Therapeutics, Inc. 01 Mar 2024 9 -$1,757 4 Chief Financial Officer 05 Mar 2024, 17:02
ACRS Aclaris Therapeutics, Inc. 01 Feb 2024 3 $0 4 Chief Financial Officer 05 Feb 2024, 19:27
ACRS Aclaris Therapeutics, Inc. 01 Jan 2024 3 -$2,663 4 Chief Financial Officer 03 Jan 2024, 16:47
ACRS Aclaris Therapeutics, Inc. 06 Sep 2023 1 +$74,971 4 Chief Financial Officer 07 Sep 2023, 16:16
ACRS Aclaris Therapeutics, Inc. 01 Sep 2023 3 -$2,252 4 Chief Financial Officer 05 Sep 2023, 17:08
ACRS Aclaris Therapeutics, Inc. 01 Mar 2023 10 -$23,579 4 Chief Financial Officer 03 Mar 2023, 19:09
ACRS Aclaris Therapeutics, Inc. 01 Feb 2023 2 $0 4 Chief Financial Officer 03 Feb 2023, 15:55
ACRS Aclaris Therapeutics, Inc. 01 Jan 2023 0 $0 3 Chief Financial Officer 06 Jan 2023, 15:31